.

Neurocrine Biosciences reported $-15300000 in Operating Profit for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Abbvie ABBV:US $ 3295M 1422M
Acadia Pharmaceuticals ACAD:US $ -33.65M 79.36M
Acorda Therapeutics ACOR:US $ -13.92M 2.79M
Agios Pharmaceuticals AGIO:US $ -94.94M 3.5M
ALKERMES ALKS:US -34457000 7.87M
Alnylam Pharmaceuticals ALNY:US $ -191.69M 44.95M
Amgen AMGN:US $ 2176M 324M
Aptinyx Inc APTX:US $ -17105000 2.27M
Biogen BIIB:US $ -59.1M 669.8M
Biomarin Pharmaceutical BMRN:US $ 39.15M 98.18M
Cytokinetics CYTK:US $ -10.87M 69.68M
Dynavax Technologies DVAX:US $ 128.23M 97.46M
Enanta Pharmaceuticals ENTA:US $ -32.54M 1.31M
Exelixis EXEL:US $ 83.71M 0.46M
Gilead Sciences GILD:US $ 2029M 1832M
Halozyme Therapeutics HALO:US $ 34.06M 41.61M
Intercept Pharmaceuticals ICPT:US $ -13.36M 3.09M
Intra Cellular Therapies ITCI:US $ -87.92M 15.26M
IONIS PHARMACEUT IONS:US $ -85.51M 28.01M
Nektar Therapeutics NKTR:US $ -152.84M 36.28M
Neurocrine Biosciences NBIX:US $ -15.3M 18.4M
Pfizer PFE:US $ 12102M 2229M
Prothena PRTA:US -43209000 5.26M
Regeneron Pharmaceuticals REGN:US $ 1109.9M 148.6M
Repligen RGEN:US $ 63.17M 3.17M
Rigel Pharmaceuticals RIGL:US $ -12.96M 13.3M
Sarepta Therapeutics SRPT:US $ -211.13M 124.25M
Teva Pharmaceutical TEVA:IT -949000000 236M
Ultragenyx Pharmaceutical RARE:US $ -141.59M 4.96M
Vertex Pharmaceuticals VRTX:US $ 1106.3M 65.4M
Xoma XOMA:US $ -4767000 2.7M
YTE INCY:US $ 254.43M 137.89M